Skip to Content

Embecta Corp EMBC

Morningstar Rating
$16.35 +0.13 (0.80%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EMBC is trading at a 34% premium.
Price
$16.35
Fair Value
$28.17
Uncertainty
Very High
1-Star Price
$64.24
5-Star Price
$48.87
Economic Moat
Ckdsyx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EMBC is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$16.22
Day Range
$15.5416.44
52-Week Range
$9.9323.75
Bid/Ask
$16.40 / $16.36
Market Cap
$942.91 Mil
Volume/Avg
549,835 / 445,842

Key Statistics

Price/Earnings (Normalized)
4.77
Price/Sales
0.84
Dividend Yield (Trailing)
3.67%
Dividend Yield (Forward)
3.67%
Total Yield
3.67%

Company Profile

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Value
Total Number of Employees
2,200

Comparables

Valuation

Metric
EMBC
OM
MMSI
Price/Earnings (Normalized)
4.7727.70
Price/Book Value
2.134.07
Price/Sales
0.841.543.96
Price/Cash Flow
8.5622.28
Price/Earnings
EMBC
OM
MMSI

Financial Strength

Metric
EMBC
OM
MMSI
Quick Ratio
1.505.204.22
Current Ratio
2.296.426.03
Interest Coverage
1.45−10.396.17
Quick Ratio
EMBC
OM
MMSI

Profitability

Metric
EMBC
OM
MMSI
Return on Assets (Normalized)
12.15%−38.44%9.17%
Return on Equity (Normalized)
−83.38%15.14%
Return on Invested Capital (Normalized)
28.15%−43.78%10.93%
Return on Assets
EMBC
OM
MMSI
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
WnmcptpcvWvpls$161.4 Bil
Becton Dickinson & Co
BDX
LjbjrzvpmFhkjscb$68.6 Bil
Alcon Inc
ALC
KdmhmqhjpCcclkx$44.9 Bil
ResMed Inc
RMD
LqdsygcqvWyltr$30.3 Bil
Coloplast A/S ADR
CLPBY
RdndflsmgNzgk$29.3 Bil
West Pharmaceutical Services Inc
WST
HhfntchcDlwp$23.7 Bil
The Cooper Companies Inc
COO
WlzrkdcdNpqvj$18.3 Bil
Hologic Inc
HOLX
MjvrtnrpXjpyvwn$18.3 Bil
Baxter International Inc
BAX
LgbjlqgnNcxfbx$18.1 Bil
Teleflex Inc
TFX
XdpMxk$10.6 Bil

Sponsor Center